Tech Company Acquirers

BioCryst Pharmaceuticals

Presidio Pharmaceuticals was purchased by BioCryst Pharmaceuticals, a leading biopharmaceutical growth company, based in Durham.

Company Overview

Company Name
BioCryst Pharmaceuticals
Company Status
Publicly-held
Industry
Biopharmaceutical
Acquisitions

Contact Information

Mailing Address
4505 Emperor Blvd. 200
Durham, NC 27703
USA
Email Address

Company Background Information

Overview
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
Profile
BioCryst Pharmaceuticals LinkedIn Company Profile
Social Media
BioCryst Pharmaceuticals Company Twitter Account
Company News
BioCryst Pharmaceuticals News
Facebook
BioCryst Pharmaceuticals on Facebook
YouTube
BioCryst Pharmaceuticals on YouTube
Last Transaction
10/19/2012

Acquisitions By BioCryst Pharmaceuticals

Date
Company
Amount
10/19/2012
$101,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Jon Stonehouse
  Jon Stonehouse LinkedIn Profile  Jon Stonehouse Twitter Account  Jon Stonehouse News  Jon Stonehouse on Facebook
Chief Financial Officer
Thomas Staab
  Thomas Staab LinkedIn Profile  Thomas Staab Twitter Account  Thomas Staab News  Thomas Staab on Facebook
Chief Medical Officer
William Sheridan
  William Sheridan LinkedIn Profile  William Sheridan Twitter Account  William Sheridan News  William Sheridan on Facebook
VP - General Counsel
Alane Barnes
  Alane Barnes LinkedIn Profile  Alane Barnes Twitter Account  Alane Barnes News  Alane Barnes on Facebook
VP - Regulatory Affairs
Elliott Berger
  Elliott Berger LinkedIn Profile  Elliott Berger Twitter Account  Elliott Berger News  Elliott Berger on Facebook


 

 

Browse more tech company acquirers:

BioClinica | Biodesix

 

Share this article

 


About Our Venture Capital Transactions Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary